Literature DB >> 10540096

Structured sedation programme for magnetic resonance imaging examination in children.

I N Keengwe1, S Hegde, O Dearlove, B Wilson, R W Yates, A Sharples.   

Abstract

One thousand, eight hundred and fifty-seven patients underwent magnetic resonance imaging following the establishment of a structured sedation programme. Forty-eight of these patients came from the intensive care unit with a secure airway and were therefore excluded from any further analysis. Oral sedation was to be given to children aged 5 years and below. For children >/= 6 years old, oral sedation could be given only if their level of co-operation was judged to be inadequate by the referring physician. Oral sedation consisted of chloral hydrate 90 mg x kg-1 (maximum 2.0 g) orally with or without rectal paraldehyde 0.3 ml x kg-1. All magnetic resonance imaging requests for children who failed oral sedation as well as those referred for general anaesthesia from the outset were reviewed by a consultant anaesthetist who then allocated patients to undergo the procedure with either general anaesthesia or intravenous sedation. Scans requiring intravenous sedation or general anaesthesia were performed in the presence of a consultant anaesthetist. Intravenous sedation consisted of either a propofol 0.5 mg x kg-1 bolus followed by an infusion (maximum 3 mg x kg-1 x h-1) or midazolam 0.2-0.5 mg x kg-1 boluses. General anaesthesia was given using spontaneous ventilation with a mixture of 66% nitrous oxide in oxygen and isoflurane following either inhalation (sevoflurane) or intravenous (propofol) induction. One thousand and thirty-nine (57.4%) of the scans were done without sedation whereas 93 scans were performed during the consultant anaesthetist supervised sessions. Oral sedation failed in 50 out of 727 patients (6.9%). Eighty-seven per cent of children aged 5 years and below needed sedation compared with 4.5% of those aged over 10 years. Two patients who had only received chloral hydrate developed significant respiratory depression. This structured sedation programme has provided a safe, effective and efficient use of limited resources.

Entities:  

Mesh:

Year:  1999        PMID: 10540096     DOI: 10.1046/j.1365-2044.1999.01106.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

1.  Sedation in Japanese dental schools.

Authors:  Zac Morse; Kimito Sano; Kazuyuki Fujii; Tomio Kanri
Journal:  Anesth Prog       Date:  2004

Review 2.  Sedation and analgesia for brief diagnostic and therapeutic procedures in children.

Authors:  Sascha Meyer; Ulrich Grundmann; Sven Gottschling; Stefan Kleinschmidt; Ludwig Gortner
Journal:  Eur J Pediatr       Date:  2007-01-05       Impact factor: 3.183

Review 3.  [MR urography: principles, examination techniques, indications].

Authors:  M Memarsadeghi; M Riccabona; G Heinz-Peer
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

4.  Application of magnetic resonance urography in diagnosis of congenital urogenital anomalies in children.

Authors:  Seyedmehdi Payabvash; Abdol-Mohammad Kajbafzadeh; Parisa Saeedi; Zhina Sadeghi; Azadeh Elmi; Mehrzad Mehdizadeh
Journal:  Pediatr Surg Int       Date:  2008-07-31       Impact factor: 1.827

Review 5.  Pediatric MRU--its potential and its role in the diagnostic work-up of upper urinary tract dilatation in infants and children.

Authors:  Michael Riccabona
Journal:  World J Urol       Date:  2004-06-09       Impact factor: 4.226

Review 6.  [Pitfalls in magnetic resonance imaging. What should the anaesthesiologist know?].

Authors:  S v Paczynski; K P Braun; W Müller-Forell; C Werner
Journal:  Anaesthesist       Date:  2007-08       Impact factor: 1.041

7.  Repair of soft tissue and extensor tendon defects on the dorsum of the hand by transfer of dorsal foot flap and extensor digitorum brevis tendon in a 3-year-old child: A case report.

Authors:  Heng Tian; Debiao Song; Hongjuan Jin; Quanzhe Liu; Yongheng Zhao; Xuejie Wang; Wenrui Qu; Rui Li
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.